STADA Competitors and Similar CompaniesClear all
STADA's competitors and similar companies include Karyopharm Therapeutics.
 Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. | ||
Founding Date | Founding Date 1895 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more | Locations Newton, US HQ Givatayim, IL |
Employees | Employees 12,33911% increase | Employees 22818% decrease |
Valuation ($) | Valuation ($) 6 b | Valuation ($) 111.7 m |
Financial | ||
Revenue (est.) | Revenue (est.) €3b (FY, 2020) | Revenue (est.) $146.1m (FY, 2025) |
Cost of goods | Cost of goods €1.3b (FY, 2020) | Cost of goods $5.9m (FY, 2025) |
Gross profit | Gross profit €1.7b (FY, 2020) | Gross profit $140.1m (FY, 2025) |
Net income | Net income €181.9m (FY, 2020) | Net income ($196m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Karyopharm Therapeutics
HQ
Newton, US
Employees
228↓ 18% decrease
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
View company